• MCC Therapeutics, Inc. will present Phase 1 Clinical Results of MCCSA2 at the World Bronchiectasis Conference (WBC2026) in Hanover, Germany

    Published On: June 24, 2026

  • MCC Therapeutics announces the Publication of its Scientists’ Paper in the Journal of Clinical Investigation

    Published On: June 5, 2026

  • New hope from old drugs for cystic fibrosis: startup explores combination therapy

    Published On: October 7, 2025

  • Annual Update for 2025

    Published On: September 15, 2025

  • Combined agonists act synergistically to increase mucociliary clearance in a cystic fibrosis airway model

    Published On: September 22, 2021

  • Inhibition of airway surface fluid absorption by cholinergic stimulation

    Published On: February 5, 2016